我们的网站为什么显示成这样?

可能因为您的浏览器不支持样式,您可以更新您的浏览器到最新版本,以获取对此功能的支持,访问下面的网站,获取关于浏览器的信息:

|本期目录/Table of Contents|

心肌梗死前有无心绞痛对心肌损害程度的影响(PDF)

《心脏杂志》[ISSN:1009-7236/CN:61-1268/R]

期数:
2005年第1期
页码:
64-66
栏目:
临床研究
出版日期:
2005-01-05

文章信息/Info

Title:
The effect of acute myocardial infarction with or without preinfarction angina on the myocardial damage level
作者:
范长青1李敬文2裴兆辉3田 野4 杨 巍4傅世英41
1.解放军174医院心内科:福建 厦门 360001; 2.哈尔滨医科大学第一临床医学院神经外科:黑龙江 哈尔滨 150001; 3.解放军107医院:山东 烟台 264002; 4. 哈尔滨医科大学第一临床医学院心内科:黑龙江 哈尔滨 150001
Author(s):
FAN Changqing1 LI Jingwen2 PEI Zhaohui3 TIAN Ye4 YANG Wei4 FU Shiying4
1. Department of Cardiology, 174 Hospital of P.L.A., Xiamen, Fujian 360001,China; 2. Department of Neurosurgery, First Affiliated Hospital of Harbin Medical University,Harbin,Heilongjiang 150001,China; 3. Department of Cardiology, 107 Hospital of P.L.A.,
关键词:
心绞痛梗死前心肌缺血预适应C反应蛋白质血管紧张素Ⅱ
Keywords:
preinfarction anginamyocardial ischemic preconditioningcreactive protein angiotensinⅡ
分类号:
R542.22; R5414
DOI:
-
文献标识码:
A
摘要:
目的 探讨心肌缺血预适应和炎症在急性心肌梗死(AMI)中的关系。方法 根据AMI发作前24 h内有无心绞痛分为实验组和对照组,使用美国Beckman公司生产的IMMAGE特种类型蛋白分析仪,测定血清C反应蛋白(CRP)浓度;放免法测定其血管紧张素Ⅱ(AngⅡ)含量;冠状动脉造影判断血管再通的前向血流。结果 不同的时间点CRP浓度在两组间无显著差异;不同时间点的AngⅡ水平在两组之间均存在显著性差异,有梗死前心绞痛组显著低于对照组;不同的时间点测得的LVEF两组之间亦分别存在显著性差异,有梗死前心绞痛组显著高于对照组。住院期间病死率和心力衰竭发生率有梗死前心绞痛组显著低于对照组。结论 梗死前心绞痛对AMI有类似心肌缺血预适应的保护作用;低水平AngⅡ可能在心肌缺血预适应的心肌保护中起重要作用。炎症和心肌缺血预适应在AMI中未发现关联。
Abstract:
AIM To investigate the relation between myocardium ischemic preconditioning and inflammatory process in acute myocardial infarction(AMI) patients. METHODS Preinfarction angina group and control group were classified according to AMI patients with or without preinfarction angina. PTCA+stent performance was used to open infarct related coronary artery to TIMI 3 grades blood flow. Serum creactive protein(CRP) in AMI patients was measured on an automated biochemistry analyzer(Beckman. Com.US). Angiotensin Ⅱ was detected by the radioimmunity assay. RESULTS ①There was no significant difference in serum CRP concentration of each collected sample between the preinfarction angina group and the control group(P>0.05). ②There was a significant difference in angiotensin Ⅱ concentration of each collected comparedsample between preinfarction angina group and the control group(P<0.01). Angiotensin Ⅱ concentration of the preinfarction angina group was much lower than that of the control group. ③There was a significant difference in left ventricular ejection fraction(LVEF) of each collected comparedsample between the two groups (P<0.01). The value of LVEF was much higher in the preinfarction angina group than in the control group. CONCLUSION The protective effect of preinfarction angina is similar to myocardial ischemic preconditioning in AMI patients. Lower serum level of angiotension Ⅱ in AMI patients with preinfarction angina may play an important role in myocardial protection in ischemic preconditioning. No significant relation is suggested between inflammatory process and myocardial ischemic preconditioning.

参考文献/References

[1] TIMI Study Group. The Thrombolysis in myocardial Infarction (TIMI) trial. Phase I findings[J]. N Engl J Med,1985,312(14):932-936.

[2] Murry CE, Jennings RB, Reimer KA. Preconditioning with ischemia: a delay of lethal cell injury in ischemic myocardium[J]. Circulation, 1986, 74: 1124-1136.

[3] Anzai T, Yoshikawa T, Asakura Y, et al. Preinfarction angina as a major predictor of left ventricular function and longterm prognosis after a first Q wave myocardial infarction[J]. J Am Coll Cardiol,1995,26(2): 319-327.

[4] Dana A, Sumeray MS, Yellon DM. Ischaemic preconditioning: a clinical perspective[J]. Hosp Med,1998,59: 216-220.

[5] 张航向,龚卫琴,陶凌. 心肌缺血预适应对单支动脉闭塞性急性心肌梗死患者的影响[J].心脏杂志,2000,12(4):273-275.

[6] Yellon DM, Baxter GF. A “second window of protection” or delayed protection preconditioning phenomenon: future horizons for myocardial protection[J]. J Mol Cell Cardiol, 1995,27(4): 1023-1034.

[7] Reimer KA, Jennings RB. Is stunned myocardium a protective mechanism?[A]. Kloner RA, Przyklenk K. Stunned Myocardium: Properties, Mechanisms and Clinical Manifestations[M]. New York, Marcel Dekker,1993. 135-152.

[8]Steenbergen C,Perlman ME,London RE, et al. Mechanism of preconditioning:ionic alterations[J]. Circ Res,1993,72(1):112-125.

[9] de Albuquerque CP,Gerstenblith G,Weiss RG. Importance of metabolic inhibition and cellular pH in mediating preconditioning contractile and metabolic effects in rat hearts[J]. Circ Res,1994,74(1):139-150.

备注/Memo

备注/Memo:
收稿日期:2004-03-10.
更新日期/Last Update: 2010-01-05